Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study
<p>Abstract</p> <p>Background</p> <p>The main focus of several studies concerned with cancer progression and metastasis is to analyze the mechanisms that allow cancer cells to interact and quickly adapt with their environment. Integrins, a family of transmembrane glycop...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-08-01
|
| Series: | Diagnostic Pathology |
| Subjects: | |
| Online Access: | http://www.diagnosticpathology.org/content/7/1/104 |
| _version_ | 1831748777927507968 |
|---|---|
| author | dos Santos Petra Zanetti Juliana S Ribeiro-Silva Alfredo Beltrão Eduardo IC |
| author_facet | dos Santos Petra Zanetti Juliana S Ribeiro-Silva Alfredo Beltrão Eduardo IC |
| author_sort | dos Santos Petra |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>The main focus of several studies concerned with cancer progression and metastasis is to analyze the mechanisms that allow cancer cells to interact and quickly adapt with their environment. Integrins, a family of transmembrane glycoproteins, play a major role in invasive and metastatic processes. Integrins are involved in cell adhesion in both cell-extracellular matrix and cell-cell interactions, and particularly, β1 integrin is involved in proliferation and differentiation of cells in the development of epithelial tissues. This work aimed to investigate the putative role of β1 integrin expression on survival and metastasis in patients with breast invasive ductal carcinoma (IDC). In addition, we compared the expression of β1 integrin in patients with ductal carcinoma in situ (DCIS).</p> <p>Methods</p> <p>Through tissue microarray (TMA) slides containing 225 samples of IDC and 67 samples of DCIS, β1 integrin expression was related with several immunohistochemical markers and clinicopathologic features of prognostic significance.</p> <p>Results</p> <p>β1 integrin was overexpressed in 32.8% of IDC. In IDC, β1 integrin was related with HER-2 (p = 0.019) and VEGF (p = 0.011) expression and it had a significant relationship with metastasis and death (p = 0.001 and p = 0.05, respectively). Kaplan-Meier survival analysis showed that the overexpression of this protein is very significant (p = 0.002) in specific survival (number of months between diagnosis and death caused by the disease). There were no correlation between IDC and DCIS (p = 0.559) regarding β1 integrin expression.</p> <p>Conclusions</p> <p>Considering that the expression of β1 integrin in breast cancer remains controversial, specially its relation with survival of patients, our findings provide further evidence that β1 integrin can be a marker of poor prognosis in breast cancer.</p> <p>Virtual slides</p> <p>The virtual slide(s) for this article can be found here: <url>http://www.diagnosticpathology.diagnomx.eu/vs/6652215267393871</url></p> |
| first_indexed | 2024-12-21T21:57:37Z |
| format | Article |
| id | doaj.art-7ee65e1d209a4b909b1bd35907a502ab |
| institution | Directory Open Access Journal |
| issn | 1746-1596 |
| language | English |
| last_indexed | 2024-12-21T21:57:37Z |
| publishDate | 2012-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Diagnostic Pathology |
| spelling | doaj.art-7ee65e1d209a4b909b1bd35907a502ab2022-12-21T18:48:56ZengBMCDiagnostic Pathology1746-15962012-08-017110410.1186/1746-1596-7-104Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical studydos Santos PetraZanetti Juliana SRibeiro-Silva AlfredoBeltrão Eduardo IC<p>Abstract</p> <p>Background</p> <p>The main focus of several studies concerned with cancer progression and metastasis is to analyze the mechanisms that allow cancer cells to interact and quickly adapt with their environment. Integrins, a family of transmembrane glycoproteins, play a major role in invasive and metastatic processes. Integrins are involved in cell adhesion in both cell-extracellular matrix and cell-cell interactions, and particularly, β1 integrin is involved in proliferation and differentiation of cells in the development of epithelial tissues. This work aimed to investigate the putative role of β1 integrin expression on survival and metastasis in patients with breast invasive ductal carcinoma (IDC). In addition, we compared the expression of β1 integrin in patients with ductal carcinoma in situ (DCIS).</p> <p>Methods</p> <p>Through tissue microarray (TMA) slides containing 225 samples of IDC and 67 samples of DCIS, β1 integrin expression was related with several immunohistochemical markers and clinicopathologic features of prognostic significance.</p> <p>Results</p> <p>β1 integrin was overexpressed in 32.8% of IDC. In IDC, β1 integrin was related with HER-2 (p = 0.019) and VEGF (p = 0.011) expression and it had a significant relationship with metastasis and death (p = 0.001 and p = 0.05, respectively). Kaplan-Meier survival analysis showed that the overexpression of this protein is very significant (p = 0.002) in specific survival (number of months between diagnosis and death caused by the disease). There were no correlation between IDC and DCIS (p = 0.559) regarding β1 integrin expression.</p> <p>Conclusions</p> <p>Considering that the expression of β1 integrin in breast cancer remains controversial, specially its relation with survival of patients, our findings provide further evidence that β1 integrin can be a marker of poor prognosis in breast cancer.</p> <p>Virtual slides</p> <p>The virtual slide(s) for this article can be found here: <url>http://www.diagnosticpathology.diagnomx.eu/vs/6652215267393871</url></p>http://www.diagnosticpathology.org/content/7/1/104β1 integrinTissue microarrayImmunohistochemistryPrognosis |
| spellingShingle | dos Santos Petra Zanetti Juliana S Ribeiro-Silva Alfredo Beltrão Eduardo IC Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study Diagnostic Pathology β1 integrin Tissue microarray Immunohistochemistry Prognosis |
| title | Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study |
| title_full | Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study |
| title_fullStr | Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study |
| title_full_unstemmed | Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study |
| title_short | Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study |
| title_sort | beta 1 integrin predicts survival in breast cancer a clinicopathological and immunohistochemical study |
| topic | β1 integrin Tissue microarray Immunohistochemistry Prognosis |
| url | http://www.diagnosticpathology.org/content/7/1/104 |
| work_keys_str_mv | AT dossantospetra beta1integrinpredictssurvivalinbreastcanceraclinicopathologicalandimmunohistochemicalstudy AT zanettijulianas beta1integrinpredictssurvivalinbreastcanceraclinicopathologicalandimmunohistochemicalstudy AT ribeirosilvaalfredo beta1integrinpredictssurvivalinbreastcanceraclinicopathologicalandimmunohistochemicalstudy AT beltraoeduardoic beta1integrinpredictssurvivalinbreastcanceraclinicopathologicalandimmunohistochemicalstudy |